Due diligence on a high-dimensional scientific claim, graded dimension by dimension.
Covers omics, CRISPR screens, clinical trials, real-world evidence, AI clinical decision support, diagnostics, preclinical models, cell and gene therapy and structural biology. Returns the questions a domain reviewer would ask, the failure patterns that caught comparable claims before, and evidence from Europe PMC, ClinicalTrials.gov, openFDA, NIH RePORTER and SEC EDGAR with a hard identifier on every source, ch
https://api.zetesis.science/mcpZetesis: scientific due diligence on a claim, grounded in retrieved public evidence (Europe PMC, ClinicalTrials.gov, openFDA, NIH RePORTER, SEC EDGAR). Free: no account, no key, no model cost.
Use Zetesis when assessing a specific empirical scientific, clinical or technical claim:
a claim is stated, questioned, or about to be written down (paper, preprint, deck, grant, draft);
due diligence, screening or red-teaming a result, a startup's science or a portfolio company's data;
whether a finding replicates, or has a retraction or correction notice, or what a reviewer would ask;
retrieving evidence before citing a paper, trial or statistic. Routine coding, casual discussion and wording-only edits do not require it.
If Zetesis tools are deferred and this client provides tool search, search for "zetesis_scope" and "zetesis_evidence" to load their schemas. Otherwise use the available tools directly.
Domains: omics and genetics, CRISPR screens, clinical trials, real-world evidence, AI diagnostics, preclinical models, cell and gene therapy, structural biology, materials, energy, AI/ML.
4 in the Claude listing